| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Dibiase Mary is a Chief Operating Officer at X4 Pharmaceuticals, Inc. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $5.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | XFOR X4 Pharmaceuticals, Inc | Chief Operating Officer | Sell | 18,192 | $0.84 | $15,281.28 | -10.6% | +142.9% | -0.6% | |
| Feb 13, 2023 | XFOR X4 Pharmaceuticals, Inc | Chief Operating Officer | Sell | 4,348 | $0.93 | $4,043.64 | -2.5% | +60.9% | -2.6% | |
| Aug 17, 2022 | XFOR X4 Pharmaceuticals, Inc | Chief Operating Officer | Sell | 1,713 | $0.00 | - | -1.0% | +63.8% | +2.6% | |
| Jun 30, 2022 | XFOR X4 Pharmaceuticals, Inc | Chief Operating Officer | Sell | 1,578 | $0.00 | - | -0.9% | +50.3% | +101.0% | |
| Jun 24, 2022 | XFOR X4 Pharmaceuticals, Inc | Chief Operating Officer | Sell | 856 | $0.00 | - | -0.5% | -13.5% | +83.2% | |
| Jun 16, 2022 | XFOR X4 Pharmaceuticals, Inc | Chief Operating Officer | Sell | 856 | $0.00 | - | -0.5% | +4.7% | +101.9% | |
| Feb 11, 2022 | XFOR X4 Pharmaceuticals, Inc | Chief Operating Officer | Sell | 12,545 | $0.00 | - | -13.9% | -33.3% | -37.8% |